Molecular Biology Enzymes And Kits & Reagents Diagnosis Market is segmented By Product Type( Kits & Reagents, Enzymes, Polymerases, Restriction Endonucleases, Reverse Transcriptases, Other), By Application (PCR, Sequencing, Cloning, Epigenetics, Other), By End-User(Academic & Research Institutes, Pharmaceutical & Biotechnology companies, Hospitals & Diagnostic Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
The Molecular Biology Enzymes and Kits & Reagents Market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a high CAGR during the forecast period (2023-2030).
The study of the molecular basis of biological activity is known as molecular biology. Molecular biology provides new insights into the nature of genes and proteins, as well as their interactions. In contrast, time-honoured biochemical and physiological approaches can demonstrate how the disease affects function at the cell, tissue, organ, and individual levels.
Molecular Biology Enzymes And Kits & Reagents Diagnosis Market Scope
|
Metrics |
Details |
|
Market CAGR |
High |
|
Segments Covered |
By Product Type, By Ingredient, By Form, By Application, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Market Dynamics
The factors driving the molecular biology enzymes and kits & reagents diagnosis market are growing research and development.
The growing research and development is expected to drive the global molecular biology enzymes and kits & reagents diagnosis market in the forecast period
Gene mutations are important in the etiology and progression of diseases and disorders such as immune system disorders, metabolic diseases, cancer, and in-born genetic disorders. As a result, understanding the etiology of specific diseases and developing treatment plans can be significantly aided by detailed knowledge of the human genome. The growing number of genome projects around the world, combined with lower genetic analysis costs, aids in advancing research in various fields, including disease treatment, personalized medicine, and microbial genetics. The availability of vast and remarkable data resources has encouraged and enhanced numerous advances in science and technology within and beyond genetics and genomics. The approach used in these diseases has been successfully applied to a wide range of other complex diseases. The bacteriophage T4 DNA ligase is the most commonly used in molecular biology. T4 DNA ligase is a 68 kDa monomer that requires the cofactors Mg2+ and ATP. T4 DNA ligase can repair single-stranded nicks in duplex DNA, RNA, or DNA/RNA hybrids and connect blunt and cohesive ends. Since molecular cloning has become a standard laboratory technique, manufacturers provide a plethora of enzymes for the generation and manipulation of nucleic acids.
The limitations are expected to hamper the molecular biology enzymes and kits & reagents diagnosis market
The reimbursement policies for genetic tests are rigid. Unless prescribed by a physician, most health insurance plans in the United States do not cover the cost of genetic testing. The provider's policy solely determines coverage and reimbursement. For example, Medicare covers genetic testing for people with cancer who qualify for Medicare genetic testing for an inherited mutation. Such concerns are stifling market growth around the world.
COVID-19 Impact Analysis
COVID-19 is an acute respiratory infectious disease caused by the SARS coronavirus 2 (SARSCoV2). COVID-19, which was largely unknown before the outbreak began in Wuhan (China) in December 2019, has quickly progressed from a regional crisis to a global pandemic. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. Researchers have been working to develop diagnostic methods and treatments to combat this pandemic. Because of their accuracy and reliability in detecting genetic materials from the virus in the host's body, PCR tests have been considered the "gold standard" for diagnosing COVID-19. Hence, the COVID-19 is assumed to impact the market growth.
Segment Analysis
Polymerase Chain Reaction Segment is expected to dominate the global molecular biology enzymes and kits & reagents diagnosis market
The rising prevalence of genetic, infectious, and chronic diseases is primarily responsible for the segment's growth. PCR-based tests are increasingly being used to guide patient management, especially in infectious disease, cancer, and congenital abnormalities. According to the World Health Organization, cancer is the second leading cause of death worldwide, accounting for 9.6 million deaths in 2018. PCR techniques are commonly used for tumor profiling and bacterial infection detection. PCR is also used in DNA sequencing, cloning, library generation, mutagenesis, and expression profiling. PCR duplicates the nucleic acid strands to increase the size of the DNA. Thermal cyclers and reagents such as enzymes, nucleotides, and buffers denature and anneal DNA strands during amplification.
However, technological advancements and high demand for automated workstations have increased the adoption of real-time PCR and digital PCR techniques to simplify workflow in busy, high-throughput laboratories. PCR is now a common and often necessary technique in medical and biological research labs for many applications. The PCR technique consists of three significant steps: denaturation, annealing, and extension. A growing number of diseases can be investigated and diagnosed using PCR. Human genes, as well as genes from bacteria and viruses, can be detected using qualitative PCR. It is also used in forensics laboratories and is particularly useful because it requires only a small amount of original DNA. PCR can identify genes that have been linked to cancer development. The emergence of PCR as a technique has aided molecular cloning.
Geographical Analysis
North America region accounted for the largest market share in the global molecular biology enzymes and kits & reagents diagnosis market
The increasing research funds in clinical research, the growing number of pharmaceutical and biotechnology companies, the favourable reimbursement scenario for molecular diagnostics, and the growing investments in research projects in Canada are projected to drive the market in this region. Many clinical research organizations in this region are expected to contribute to the market growth. For instance, As of 2021, there are 4,087 Contract Research Organizations businesses in the United States, a 3.4 per cent increase from 2020.
Competitive Landscape
The global molecular biology enzymes and kits & reagents diagnosis market is highly competitive with increasing research & developments, company mergers, and acquisitions. Some of the major key players in the market are Thermo Fisher, Merck, Illumina, New England Biolabs, Promega, Agilent, Roche, Takara Bio, Bio Basic, Jena Bioscience
Thermo Fisher Scientific
Overview: Thermo Fisher Scientific is based in the United States that sells scientific instruments, reagents and consumables, and software services. Waltham, Massachusetts, is the company's headquarters. The company was founded in 1956.
Product Portfolio: The company manufactures PCR enzymes and reagents for applications in molecular biology. Using well-known and trusted PCR enzymes such as Applied Biosystems AmpliTaq and AmpliTaq Gold, Invitrogen Platinum II Taq, and Platinum SuperFi II DNA polymerases.
Key Development: On April 15th, 2021, Thermo Fisher Scientific Inc. acquired PPD for $47.50 per share, for a total cash purchase price of $17.4 billion, plus the assumption of approximately $3.5 billion in net debt.
Frequently Asked Questions
What is the Projected CAGR value of the Molecular Biology Enzymes And Kits & Reagents Diagnosis Market?
Molecular Biology Enzymes And Kits & Reagents Diagnosis Market is expected to grow at a high CAGR during the forecasting period 2022-2029.
Which region controlled the global market during 2022-2029?
North America region Controls the Molecular Biology Enzymes And Kits & Reagents Diagnosis Market during 2022-2029.
Which is the fastest growing region in the Molecular Biology Enzymes And Kits & Reagents Diagnosis Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.
